Lehigh Valley Health Network Hematology and Medical Oncology

Topics

• Lymphoma Diagnosis and Treatment 33
• CAR-T cell therapy research 30
• Cancer Immunotherapy and Biomarkers 18
• Colorectal Cancer Treatments and Studies 10
• Lung Cancer Treatments and Mutations 9
• Glioma Diagnosis and Treatment 8
• Chronic Lymphocytic Leukemia Research 7
• Renal cell carcinoma treatment 6
• Genetic factors in colorectal cancer 5
• Melanoma and MAPK Pathways 5
• Bladder and Urothelial Cancer Treatments 4
• Breast Cancer Treatment Studies 4

Most cited

1. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.

   Nature medicine · 2023 · 266 citations · Suresh Nair

2. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.

   Nature medicine · 2023 · 216 citations · Ranjit Nair

3. Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy.

   Blood · 2025 · 56 citations · Ranjit Nair

4. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.

   Journal of the American College of Cardiology · 2021 · 168 citations · Muhammad Rizvi

5. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 101 citations · Suresh Nair, Paul Palyca, Bradley Lash, Muhammad Rizvi

6. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 99 citations · Tara Morrison

7. Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.

   Blood · 2021 · 193 citations · Ranjit Nair

8. Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2025 · 36 citations · Suresh Nair